Medarex is a biopharmaceutical company focused on the discovery, development, and potential commercialization of fully human antibody-based therapeutics to treat life- threatening and debilitating diseases, including cancer, inflammation, autoimmune and infectious diseases. Medarex applies its UltiMAbĀ® technology and product development and clinical manufacturing experience to generate, support and potentially commercialize a broad range of fully human antibody products for itself and its partners. Medarex is committed to building value by developing a diverse pipeline of antibody products to address the world's unmet healthcare needs.
| Website | http://www.medarex.com |
| Ticker | NASDAQ:MEDX |
| Employees | 100 (42 on RocketReach) |
| Founded | 1987 |
| Phone | +1 908-713-6000 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+67 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology, Science and Engineering, Medical Device, Health Care, Therapeutics |
| Web Rank | 76653 |
| Web Visits | 541000 |
| Keywords | Precision Medicine, Biopharmaceutical, Therapeutics, Antibody, Cancer Treatment, Drug Discovery, Pharmaceutical Development, Immunology, Biotechnology, Clinical Trials, Oncology, Inflammation Treatment, Pharmaceutical Research, Drug Development, Biologics, Monoclonal Antibodies, Immunotherapy |
| Competitors | Johnson & Johnson, Roche, AbbVie, Merck & Co., Inc., Pfizer, Sanofi, Bristol Myers Squibb, Genentech, Amgen, Lilly India +39 more (view full list) |
Looking for a particular Medarex employee's phone or email?
John Cini is the Executive Director of Medarex.
42 people are employed at Medarex.
Medarex is based in Princeton, New Jersey.